BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

FRA:BX2 (USA)  
€ 1.89 (+0.32%) May 20
At Loss
Market Cap:
€ 72.49M ($ 78.78M)
Enterprise V:
€ 98.09M ($ 106.61M)
Volume:
200.00
Avg Vol (2M):
2.93K
Also Trade In:

BioXcel Therapeutics Inc Valuation Measures